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Objectives: Reports on the sensitivity and accuracy of contrast-enhanced helical computed tomogra-
phy (HCT) in the preoperative evaluation of colorectal liver metastases (CLM) have been conflicting. Few
studies have controlled for and reported on the time interval between HCT and eventual surgery.
Methods: A multi-institution, retrospective review of consecutive patients who underwent hepatic resec-
tion for CLM from January 1999 to September 2004 was conducted. Data regarding lesion characteristics
and resectability were extracted from radiology reports, operative findings and histopathological records.
Findings in HCT were evaluated according to their sensitivity for detecting CLM and ability to predict
resectability.
Results: A total of 217 consecutive patients who underwent hepatic resection for CLM were identified.
The overall sensitivity of HCT for detection of CLM was 83.2%. Prolonged time between imaging and
surgery was a negative predictor for HCT sensitivity in univariate and multivariate analysis (P < 0.001). In
predicting resectability, preoperative HCT was accurate 77.0% of the time. The time interval to surgery
was negatively correlated with HCT prediction accuracy in univariate and multivariate analyses
(P < 0.001).
Conclusions: The utility of HCT as a preoperative tool to evaluate CLM is inversely proportional to the
time interval between imaging and surgery. This may explain conflicting reports of the accuracy of HCT
in the current literature.
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Introduction
Colorectal liver metastasis (CLM) is a significant source of mor-
bidity and mortality in patients with colorectal cancer (CRC). Up
to 25% of patients present with CLM at the time of CRC diagno-
sis; a further 40% develop CLM following primary CRC resec-
tion.1,2 Hepatic resection remains the only potentially curative
option for such patients, with reported 5-year survival rates of
around 23–58%.3–9 However, only 10–30% of patients with CLM
have surgically resectable hepatic disease.5 Thus, surgical resect-
ability, defined as the removal of all macroscopic disease with clear
margins and preservation of sufficient functioning liver, must
be determined preoperatively. In order to avoid unnecessary
surgery, the surgeon must have accurate information on the
metastases, including the number of lesions, their distribution
within the parenchyma and their encroachment on key vessels or
bile ducts, the projected size of the liver remnant, and any vascular
anomalies.
Contrast-enhanced helical computed tomography (HCT)
remains the most commonly used imaging modality for the pre-
operative evaluation of CLM. Unlike magnetic resonance imaging
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(MRI), HCT is widely available at most institutions and allows for
the evaluation of both intra- and extrahepatic disease. The devel-
opment of multi-detector HCT scanners has further improved the
sensitivity of HCT for the characterization of lesions, as well as
evaluation of the hepatic vasculature.10,11 However, the true sensi-
tivity of HCT for the detection of CLM remains unclear secondary
to ongoing variability in the literature.12 In addition, with respect
to the utility of HCT for predicting resectability, it should be
noted that a significant proportion of patients are deemed to have
unresectable disease at the time of surgery despite preoperative
HCT indicating otherwise (Table 1). As such, these patients are
subjected to the risk for morbidity and mortality associated with
unnecessary exploratory surgery.
It is proposed that the discordance within the current literature
regarding HCT sensitivity and the limited utility of HCT for pre-
dicting resectability are in part the results of a prolonged time
interval between preoperative imaging and surgery. This study
represents the first multi-institution review to examine the rela-
tionship between the time interval between imaging and surgery
and the utility of such imaging.
Materials and methods
All patients who underwent surgery for proposed hepatic resec-
tion of hepatic metastases from CRC at the University Health
Network, Mount Sinai Hospital and Sunnybrook Health Sciences
Centre (Toronto, ON, Canada) from January 1999 to September
2004 were included in the study. All three institutions employ
dedicated multidisciplinary hepatobiliary teams with appropriate
radiological expertise. Patients who received preoperative chemo-
therapy or portal vein embolization within 6 months prior to
surgery, underwent planned staged resections or did not undergo
preoperative HCT were not included in the study. Demographic
information, primary colorectal tumour location and stage,
number and dates of HCTs,HCT results, date of hepatic resection,
intraoperative findings and postoperative pathology were
extracted by reviewing the charts of all patients.
Definitions
Time interval to operation is defined as the number of days
between a preoperative HCT study and the date of hepatic resec-
tion. Sensitivity was defined as the ratio of the number of meta-
static lesions reported on preoperative HCT to the actual number
of lesions. Information from intraoperative findings and postop-
erative pathology was used to determine the actual number of
lesions present. Intraoperative ultrasonography was employed to
map the true location and number of lesions. Resected specimens
were examined by experienced pathologists at each institution
using standardized techniques involving slices of 3–5 mm in
thickness. Among other features, pathology reports contained
information on tumour numbers and sizes. Resectability is
defined as the ability to resect all lesions in a single operation. For
the purposes of this study, any patient who underwent staged
operations to remove all lesions was defined as having unresect-
able disease.
Preoperative HCT reports were thoroughly reviewed to deter-
mine resectability defined by generally accepted criteria.13 Evi-
dence in HCT of invasion of major vasculature (including the
hepatic artery proper, bilateral hepatic arteries, main portal vein,
bilateral portal veins, inferior vena cava, and any hepatic veins
within 1 cm of the inferior vena cava), bilateral bile ducts, the
common bile duct or adjacent organs (excluding the gallbladder
and diaphragm) was considered to indicate unresectable disease.
Imaging evidence of extensive liver metastasis with a predicted
hepatic remnant of less than two segments or 25% after resection
was likewise considered to indicate unresectable disease. True
resectability was determined from the operative report. Accuracy
of prediction was defined as agreement between the HCT predic-
tion and operative findings.
The correlation between the time interval to operation and the
sensitivity of preoperative HCT was determined using univariate
and multivariate linear regression analysis. The normality
assumption was tested via a normal probability plot on the residu-
als. The correlation between the time interval to operation and the
accuracy of prediction was calculated using univariate and mul-
tivariate logistic regression. In this case, accuracy of prediction
was defined as a binary outcome in which HCT predictions either
agreed or disagreed with operative or histopathological findings.
As a variable in multivariate regression, the Fong score was used to
account for oncologic factors leading to CLM unresectability. This
score was developed by Fong et al. to predict longterm survival in
patients receiving hepatic resection for CLM.3 Subsequently, the
Table 1 Sensitivity of helical computed tomography (HCT) and resectability rates in previously published studies
Study Year Patients, n HCT sensitivity Resectable Time interval
Schmidt et al.15 2000 33 94% 79% NR
Wallace et al.16 2001 179 – 81% NR
Valls et al.17 2001 157 85% 94% NR
Zacherl et al.18 2002 61 83% 87% <28 days
Bhattacharjya et al.19 2004 120 73% 83% 30 days
Soyer et al.20 2004 60 92% 100% 6 days
NR, not reported; Time interval, average time between HCT scan and hepatic resection
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score has been shown to predict resectability of CLM.14 Data
analysis was performed using sas 9.1.3 (SAS Institute, Inc., Cary,
NC, USA). An alpha level of 0.05 was defined as statistically
significant.
Results
Patient and HCT characteristics
A total of 217 patients who underwent hepatic resection at the
University Health Network, Mount Sinai Hospital or Sunnybrook
Health Sciences Centre between January 1999 and September
2004 were included in this study (Table 2). Of these, 174 (80.2%)
patients underwent resection. Of the 43 patients with lesions that
were defined as unresectable, 38 required further operations to
achieve full resection and five had unresectable disease.
A total of 293 HCT studies were performed preoperatively in
the study group (Table 2). Of these, 115 (39.2%) studies reported
the presence of multiple CLMs. The median diameter of the
largest lesion was 2.9 cm (range 0.8–15.7 cm). The average sensi-
tivity of HCT for detecting CLMs was 83.2%. Fourteen imaging
studies concluded that lesions were unresectable according to pre-
viously defined criteria. The median time between HCT imaging
and hepatic resection was 48 days (range 1–179 days).
Interval to surgery and HCT sensitivity
On univariate linear regression analysis, the time interval to
surgery was inversely correlated with the sensitivity of HCT
studies (P < 0.001) (Fig. 1). This model predicts that in order to
achieve test sensitivity of over 90%, HCT must be performed no
more than 26 days before surgery. Using age, gender, Fong score
and time interval to surgery as variables, analysis by multivariate
linear regression was performed. Time interval to surgery was the
lone significant factor in predicting HCT sensitivity for correctly
detecting CLMs (P < 0.001) (Table 3). The assumption of normal-
ity was supported by normal probability plots on residuals, which
indicated straight lines.
Interval to surgery and prediction of resectability
Of the 279 HCT studies that predicted resectable disease, 216
represented truly resectable disease and 63 represented either
unresectable disease or disease that required multiple operations.
Of 14 studies that predicted unresectable disease, 11 referred
to disease that was truly unresectable or that required multiple
operations and three referred to disease that was found to be
resectable at the time of surgery. Overall, HCT provided an accu-
rate prediction of resectability in 77.5% (227/293) of scans.
Univariate logistic regression analysis suggested that time interval
to surgery was inversely correlated with accuracy of prediction.
Using this model, HCT must be performed no more than 43 days
Table 2 Characteristics of patients and helical computed tomogra-
phy (HCT) scans included in the current study
Patient or HCT characteristic Value
Number of patients 217
Number of HCT studies 293
Number of operations 223
Mean age, years (range) 65 (37–83)
Gender
Male, n 138
Female, n 79
Site of primary tumour
Colon, n 135
Rectum, n 75
Recto-sigmoid, n 7
CLMs per HCT, n 1 (0–8)
Size of largest CLM, cm (range) 2.9 (0.8–15.7)
Time interval to resection, days (range) 48 (1–179)
Sensitivity of CLM detection, % 83.2  30.0
HCT prediction of resectability
Resectable 279
Unresectable 14
CLM, colorectal liver metastasis
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Figure 1 Relationship between sensitivity of helical computed
tomography (HCT) and time interval to surgery in 293 HCT studies.
The line represents the linear regression model. CLM, colorectal liver
metastasis
Table 3 Multivariate regression analyses of helical computed tomog-
raphy sensitivity and prediction of resectability
Variable P-value
Sensitivity Prediction of resectability
Age 0.521 0.060
Gender 0.745 0.720
Fong score 0.129 0.116
Time to surgery <0.001 <0.001
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before surgery to achieve a prediction accuracy of 80%.Multivari-
ate logistic regression with age, gender, Fong score and time inter-
val to surgery showed that time interval to surgery was the lone
significant factor in determining prediction accuracy (Table 3).
Discussion
Multiple non-invasive modalities have been applied in the preop-
erative evaluation of metastatic lesions in the liver. The choice of
imaging modality used at each institution largely depends on local
availability, technical expertise and cost. As the most commonly
used modality, HCT has been evaluated by several previous
studies for its sensitivity in detecting CLM, as well as its utility for
predicting resectability (Table 1).15–20 All such studies have com-
pared imaging results with intraoperative evaluation. Despite
their similarities in experimental design, these studies have
reported an unexpectedly wide range of values for both sensitivity
and prediction accuracy. One explanation for these discrepancies
concerns the varying lengths of time patients wait between pre-
operative imaging and hepatic resection. These time intervals were
not reported in some studies and varied from 6 days to 2 months
in others. The current study is the first multi-institution study to
evaluate the sensitivity and prediction accuracy of HCT in rela-
tion to the length of time between imaging and surgery.
The current results for the overall sensitivity and prediction
accuracy of HCT are comparable with values reported by previous
studies.15–20 Time interval to surgery was found to be a negative
predictor of both HCT sensitivity and prediction accuracy. These
correlations remained significant in multivariate regression analy-
ses, in which other variables, such as age, gender and Fong score,
were not significant predictors of either outcome measures. In
comparison with previous studies, the median time of 48 days
between imaging and surgery in our cohort is relatively pro-
longed. According to the current analysis, this may result in lower
sensitivity and prediction accuracy values. Soyer et al. compared
HCT with intraoperative findings in 32 patients with CLM and
found HCT to have a sensitivity of 92% and prediction accuracy
of 100%.20 However, we must consider that the short average time
interval between imaging and surgery of 6 days (range 3–17 days)
may account for the extraordinarily positive results. By contrast,
in studies by Zacherl et al. and Bhattacharjya et al., the mean time
intervals to surgery were 28 and 30 days, respectively.18,19 These
studies yielded slightly lower but comparable sensitivity and pre-
diction accuracy results.
Although low sensitivity and accuracy may be inherent to HCT
technology and radiology expertise, their relationship with the
time interval between imaging and surgery shown in the current
study suggests the physical growth of metastatic lesions during the
time that elapses between HCT and surgery. Several studies have
examined growth rates of untreated CLM. Havelaar et al. studied
four patients with intra-abdominal CRCmetastases with serial CT
scans and determined that the mean tumour doubling time for
CLM was 70 days.21 A more recent study in 74 patients with CLM
suggested a mean tumour doubling time of 60.1 days.22 The latter
study included only patients with surgically resectable disease and
is thus comparable with data for our present cohort. In light of
these tumour doubling times, it is conceivable that, in the present
study, lesions that were previously resectable became unresectable
over time. Similarly, lesions that were previously too small to be
detected by HCT may have grown to detectable sizes, thus falsely
lowering the reported sensitivity values.
This study has several important limitations. Firstly, resectable
lesions were defined as those that were resectable in a single opera-
tion. Thus, patients who required further operations to resect all
disease were considered unresectable in the current analysis.
However, the definition used in this study was chosen to ensure a
fair comparison because strict HCT resectability criteria that gen-
erally define resectability in a single operation were applied. Sec-
ondly, a proportion of patients in the cohort received multiple
HCT scans prior to surgery. It was not possible to determine the
reasons for repeated tests, but some patients may have represented
for re-scanning as a result of the poor quality of the initial scan.
Although such patients may have biased our sensitivity estimates,
they should not affect the correlation between time interval and
HCT sensitivity. Finally, all data regarding HCT scans were
extracted from radiology reports without secondary review of
HCT images. Although this may have slightly impacted the accu-
racy of HCT data, the imaging reports used had been produced at
institutions with dedicated multidisciplinary teams with excellent
radiological expertise.
The median time interval to surgery of 48 days observed in the
current study is relatively long compared with those reported in
other studies. In general, time between HCT and surgery is spent
on extensive preoperative evaluation and the limiting of operative
risks by treating co-morbid conditions. In jurisdictions where
health care is publically financed, such extensive medical workups
can often cause delays as a result of the volume of demand on the
system.Although institutions in other jurisdictions may not expe-
rience significant waiting times, the correlation between time
interval and HCT utility is nonetheless important.
The results of this study have some significant implications.
Firstly, it has identified that the time interval between imaging and
surgery is a significant factor that contributes to the discrepancy in
HCT sensitivity values reported in the current literature. Any
future studies of imaging sensitivity in CLM evaluation in which
intraoperative findings are used as a reference should control for
and report the time interval to surgery. Secondly, this study dem-
onstrates that, regardless of the initial quality of imaging studies,
their utility will decline unless surgery is performed in a timely
manner. There is currently no standard that defines just how
recent imaging should be prior to proceeding to hepatic resection
surgery. It is proposed that HCT investigations should be per-
formed no more than 30 days prior to the date of surgery in order
to minimize any unnecessary surgery. According to the current
models, a 30-day time interval can provide 89% sensitivity for
lesion detection and 83% accuracy for resectability prediction.
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Conclusions
The current study establishes that the utility of preoperative HCT
in evaluating CLM declines over time until hepatic resection is
performed. Any study comparing imaging modalities for the
detection of liver metastases should be reported within the
context of time interval to surgery. Ultimately, delays between
imaging and surgery lead to increased patient morbidity caused
by unnecessary surgery and greater costs to health care systems.
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